Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

72 results about "Syringin" patented technology

Syringin is a natural chemical compound first isolated from the bark of lilac (Syringa vulgaris) by Meillet in 1841. It has since been found to be distributed widely throughout many types of plants. It is also called eleutheroside B, and is found in Eleutherococcus senticosus (Siberian ginseng). It is also found in dandelion coffee. Syringin may potentially have antidiabetic effects.

Content detection method for determining effective components in longshengzhi capsule by HPLC-QQQ/MS method

The invention provides a content detection method for determining effective components in a longshengzhi capsule by an HPLC-QQQ / MS method. The chromatograph condition is that the chromatographic column takes a octadecyl-bonded silica gel column as a filling agent, 0.1% formic acid-water as a mobile phase A, 0.1% formic acid-acetonitrile as a mobile phase B, and the volume ratio of the mobile phaseA and the mobile phase B is 80% to 0%:20 to 100%, so that gradient elution is performed. According to the content detection method for determining the effective components in the longshengzhi capsuleby the HPLC-QQQ / MS method, the effective substance components of traditional Chinese medicines such as astragaloside A, hydroxysafflor yellow A, calycosin 7-o-glucoside, calycosin, ferulic Acid, syringin, n-butylphthalide, ligustilide, senkyunolide A, senkyunolide I, senkyunolide H, ligustrazine, isofraxidin, dehydrocostus lactone, amygdalin, syringin E, paeoniflorin, oxypaeoniflora, benzoylpaeoniflorin, etc., in the longshengzhi capsule can be determined. The method has the advantages of being simple in operation method, high in sensitivity and accurate in content.
Owner:SHAANXI BUCHANG PHARMA

Callus culture method of snow lotus herb

The invention discloses a callus culture method of snow lotus herb, comprising the steps of selection and asepsis of plants, induction and culture of callus and large-scale culture. The core technology of the method is selection of the following large-scale culture medium: MS+0-50g / L of cane sugar+0-10g / L of agar+0.1-5.0mg / L of alpha-naphthylacetic acid+0.1-5.0mg / L of 6-benzyladenine. During large-scale culture, an abiotic elicitor, 40-60mu mol / L of SNP+40-60mu mol / L of MJ+40-60mu mol / L of SA is added. The method is easy to operate, and the active ingredient is high in content and low in production cost, does not pollute environment and can reach the level of industrialization. Syringin produced by the culture technology in the invention is invariant, high in content, low in cost and short in cycle and is very competitive in the markets.
Owner:烟台汇鹏生物科技有限公司

Syringin for injection, preparation method and application thereof

The invention relates to a syringin for injection, a preparation method and the application thereof. The invention can provide an injection that is clinically and safely used and has the pharmacological actions of resisting fatigue, tranquilizing and allaying excitement, expanding blood vessel, reducing blood viscosity, stanching, and the like. The injection contains syringin, pharmacology-permissible pH regulating substance, a stabilizing agent and an excipient. 50-2800 mg dry substance in each injection contains 5-2000 mg of syringin, 0.04-0.8 g of excipient and 0.0001-0.1g of stabilizing agent. Of the above substance, the pH regulating substance has an adding amount for regulating the weight fraction pH value to 3.5-7.5. The product of the invention is used for preparing medicaments for resisting fatigue, tranquilizing and allaying excitement, expanding blood vessel, reducing blood viscosity, stanching, resisting dumps.
Owner:苑立超

Method for extracting syringin from ovate leaf holly bark

The invention relates to a method for extracting syringin from ovate leaf holly bark. The method comprises the following steps of: crushing the ovate leaf holly bark medicine into ovate leaf holly bark with 40-80 meshes, adding the crushed ovate leaf holly bark into an extraction kettle, collecting syringin extract by using supercritical CO2 gradient extraction, dissolving the syringin extract by using 20-40% alcohol solution, filtering, adding a polyamide resin column into filtrate to adsorb impurities, carrying out concentration under reduced pressure on over-column liquid, standing for crystallization, filtering crystals, dissolving the crystals in hot water, adding activated carbon for decolorization, carrying out concentration under reduced pressure on decolorized liquid, and then standing for crystallization, drying crystals to obtain a product. The method has the advantages of low energy consumption and less pollution and is an environmentally-friendly extraction and separation method.
Owner:苏州宝泽堂医药科技有限公司

Quantitative analysis method of six chemical components in Chinese herbal medicine compound preparation using rhizoma dioscoreae nipponicae and acanthopanax roots as Chinese herbal medicines

The invention discloses a quantitative analysis method of six chemical components in a Chinese herbal medicine compound preparation using rhizoma dioscoreae nipponicae and acanthopanax roots as Chinese herbal medicines. The quantitative analysis method comprises the following steps: (1) preparing a mixed control solution; (2) preparing a first test sample solution and a second test sample solution; (3) determining contents, namely, respectively taking the mixed control solution, the first test sample solution and the second test sample solution, performing gradient elution under high performance liquid chromatography detection conditions of using C18 bonded silica gel as a chromatographic column of a filling agent and acetonitrile-formic acid solution as a mobile phase, performing high performance liquid chromatography detection by combining a diode array detector and an evaporative light-scattering detector of detectors to obtain high performance liquid chromatograms of the mixed control solution, the first test sample solution and the second test sample solution, and determining the contents of dioscin, pseudoprotodioscin, protodioscin, chlorogenic acid, syringin and isofraxidin in a test sample by using an external standard method. The quantitative analysis method is simple, convenient and rapid to operate, high in accuracy and excellent in repeatability, and can be used for improving the quality control level of a product.
Owner:TIANJIN UNIV +1

Fingerprint map and high performance liquid chromatography identification method for Xuezhitong capsule

The invention discloses a fingerprint map and high performance liquid chromatography identification method for a Xuezhitong capsule. The invention firstly discloses an establishing method of a Xuezhitong capsule fingerprint map. The establishing method comprises the following steps: (1) adding a Xuezhitong capsule content in an extraction solvent for extraction to obtain an extracting solution, and purifying the extracting solution to obtain a test sample solution; (2) performing high performance liquid chromatographic analysis on the test sample solution to acquire a high performance liquid chromatogram; and (3) selecting a common peak from chromatographic peaks in the high performance liquid chromatogram to obtain the Xuezhitong capsule fingerprint map. The invention further discloses the Xuezhitong capsule fingerprint map established by the method. The invention also discloses a Xuezhitong capsule high performance liquid chromatography identification method. The method can accurately identify adenosine and syringin in the Xuezhitong capsule and is good in accuracy, stability and repeatability. The fingerprint map and high performance liquid chromatography identification method for the Xuezhitong capsule, established by the invention, has an application prospect in quality control of the Xuezhitong capsule.
Owner:吉林省东方制药有限公司

Syringin imprinted monolithic column preparation method

The invention relates to a syringin imprinted monolithic column preparation method, which comprises: adopting syringin as a template, adding polyethylene glycol 400, isopropanol and methanol to dissolve the template, adopting eutectic solvent choline chloride itaconic acid as a functional monomer, adding cross-linking agent ethylene glycol dimethacrylate, porogenic agent 1-butyl -3 -methyl imidazole tetrafluoroborate and initiator azo diisobutyronitrile, and carrying out a polymerization reaction to obtain the syringin molecularly imprinted monolithic column with selectivity. According to themethod, the eutectic solvent choline chloride itaconic acid is used as the functional monomer, compared with use of a traditional functional monomer 4-vinylpyridine, the method is green and environmentally friendly, meanwhile, the syringin imprinting cost is reduced, the syringin imprinting monolithic column and a blank control column are successfully synthesized in a stainless steel tubular column, and chromatographic condition optimization is conducted on the syringin imprinting monolithic column. Experimental results show that the maximum imprinting factor can reach 3.11. The method is simple in preparation, the syringin imprinted monolithic column is good in durability, and a cost-saving method is provided for separation and purification of syringin.
Owner:XINJIANG TECHN INST OF PHYSICS & CHEM CHINESE ACAD OF SCI

Pharmaceutical composition for treating diabetic retinopathy and preparation method thereof

The invention discloses a pharmaceutical composition for treating diabetic retinopathy and a preparation method thereof. The pharmaceutical composition for treating diabetic retinopathy consists of the following components in parts by weight: coarse grain mixed powder, pseudolaric acid, p-chlorophenoxy isobutyric acid, syringin, phycocyanobilin, friedelin, stigmasterol, formononetin, L-alpha-aminoadipic acid, pancreatin, L-malic acid, vitamin and L-glutamic acid. The pharmaceutical composition disclosed by the invention realizes the effects of controlling blood glucose and treating retinopathy by improving glycometabolism, focusing on blood glucose reduction assisted by the medicinal components for nourishing yin and clearing heat and resolving stasis and by improving the human immunity to enhance the tolerance and resistance against lesion; and moreover, the pharmaceutical composition is simple in technology, realizes a good curative effect and can be promoted for application.
Owner:孔德华

Saussurea involucrata extract and application thereof to preparation of cosmetics

The invention discloses a saussurea involucrata extract. The saussurea involucrata extract contains 0.5-1.2% of syringin, 7-17% of chlorogenic acid and 8-25% of rutin in percentage by weight. The saussurea involucrata extract is obtained according to the following steps: S1, crushing saussurea involucrata, then putting into an extraction tank, extracting with ethanol, and combining the extracts; S2, filtering, cooling and centrifuging the extract to obtain a supernatant; S3, concentrating the supernatant to obtain a concentrate; S4, adding macroporous resin to the concentrate for purification,then eluting with ethanol, fractionally collecting the effluent, concentrating the effluent into thick paste or making the effluent into dry paste powder, thereby obtaining the saussurea involucrataextract. The supernatant is concentrated by using an MVR evaporator, so that the operation is stable, the degree of automation is high, the power consumption is low, and the operating cost is low; inaddition, the process is simple, the practicability is strong, and partial load operation characteristics are excellent; and the saussurea involucrata extract has the functions of absorbing ultraviolet rays, resisting radiation, resisting inflammation, easing pains, resisting ageing and the like in cosmetics.
Owner:GUANGZHOU JINSME FINE CHEM CO LTD

Pharmaceutical composition for treating neurasthenia and preparation method thereof

ActiveCN104490904ASignificantly calms the mind and calms the mindComprehensive application effect is idealNervous disorderDigestive systemSyringinCurative effect
The invention relates to a pharmaceutical composition for treating neurasthenia and a preparation method thereof. The pharmaceutical composition comprises the following active ingredients: 0.03-0.5mg / ml eleutheroside E, 0.05-0.5mg / ml syringin, 0.005-0.05mg / ml isofraxidin and 0.03-0.5mg / ml schizandrin; preferably, 0.05-0.2mg / ml eleutheroside E, 0.1-0.3mg / ml syringin, 0.01-0.03mg / ml isofraxidin and 0.05-0.2mg / ml schizandrin. The pharmaceutical composition provided by the invention has the advantages that the preparation process is simple and feasible, the properties of the traditional Chinese medicine components are fully considered in the preparation process, excessive impurities are removed by macroporous adsorption resin to improve the concentration of active ingredients in the preparation and play the effects of the traditional Chinese medicine components; meanwhile, the used resin can be repeatedly used, so that resource consumption can be reduced. The traditional Chinese medicine composition prepared in the invention has a remarkable curative effect.
Owner:安徽九洲方圆制药有限公司

Method for measuring effective content of acanthopanax in medicine

InactiveCN101368934AOvercome the disadvantages that the content of active ingredients is not easy to control and affect clinical applicationGuarantee product qualityComponent separationTheoretical plateMethanol water
The invention relates to a method for measuring the effective content of acanthopanax root in medicine. Based on the chromatographic conditions of high-performance liquid chromatography measurement, the method uses octadecyl bonded silica as the filler, and takes methanol-water as the mobile phase, with the detection wavelength reaching 265nm; the theoretical plate number is not less than 3000 in accordance with syringin wave peak calculation; firstly, the reference substance solution with 0.02mg of syringin in each 1ml of the solution is prepared; then 1g of the measured medicine is put into a 50ml-measuring flask and diluted to 50ml scale with methanol; 5ml of subsequent filtrate is processed through decompression and drying and then added to a treated C18 solid extraction column; 4ml of 30% methanol eluate and 30% methanol solution are collected and diluted to 5ml scale so as to prepare the sample solution; 10ul of the reference substance solution and 10ul of the sample solution are respectively extracted and injected into the liquid chromatography to measure the acanthopanax root content based on syringin. The method is convenient and fast and has accurate measurement standards to ensure the product quality and efficacy of the medicine containing acanthopanax root.
Owner:山东仙河药业有限公司

Method for extracting syringin compound from tobaccos

The invention discloses a method for extracting a syringin compound from tobaccos. The method is characterized by comprising the following steps: preparing a tobacco extract; dissolving the tobacco extract into water, and extracting; eluting an extraction solution with ethanol in a macroporous resin column; collecting eluate, performing reduced pressure concentration, performing capillary sampling thin-layer chromatography, and combining eluate containing the similar components; performing reduced pressure concentration till a solid state to obtain a polar tobacco extract; performing thin-layer chromatography, combining samples with amaranth spots, and performing reduced pressure concentration to obtain a crude extract; uniformly stirring the crude extract and silica gel, separating by using a normal phase silica gel chromatographic column, and eluting; through the chromatographic column, combining fragrance-forming substances according to different Rf values and different polarities to obtain a fine extract; performing normal phase column chromatography on the fine extract, and eluting, segmenting into 5 parts A-E during TLC detection, performing gel column chromatography on a segment B, feeding the segment B into a semi-preparative chromatography system, and separating; under chromatographic conditions, retaining for 14.32 minutes, and separating to obtain the monomer compound.
Owner:GUIZHOU TOBACCO SCI RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products